BJ's Wholesale Club Holdings, Inc. (NYSE:BJ) Q2 2025 Earnings Conference Call August 22, 2025 8:30 AM ET Company Representatives Laura L. Felice - Executive VP & CFO Robert W. Eddy - President, CEO & Chairman William C. Werner - Executive Vice President of Strategy & Development Conference Call Participants Edward Joseph Kelly - Wells Fargo Securities, LLC, Research Division Katharine Amanda McShane - Goldman Sachs Group, Inc., Research Division Mark David Carden - UBS Investment Bank, Research Division Mic ...

Core Viewpoint - Jeffs' Brands Ltd has announced the completion of a private placement of convertible debentures by its subsidiary Fort Technology Inc, raising CAD 5 million, which will be used for working capital and loan support [1][5]. Group 1: Private Placement Details - The private placement of convertible debentures has a maturity date of two years from issuance and carries an interest rate of 10% per annum, with quarterly payments starting from the closing date until September 30, 2025 [2]. - The principal amount of the convertible debentures can be converted into units of Fort at a price of CAD 0.185 per unit, with each unit consisting of one common share and one warrant [2]. - The private placement values Fort at approximately CAD 27 million [2]. Group 2: Company Participation and Compliance - Jeffs' Brands and its CEO participated in the private placement, with the company purchasing CAD 2.2 million worth of convertible debentures, qualifying it as a related-party transaction [4]. - The private placement was conducted under certain prospectus exemptions and is subject to a holding period in compliance with applicable securities laws and TSX Venture Exchange rules [3]. Group 3: Company Background - Jeffs' Brands aims to transform e-commerce by creating and acquiring products to become market leaders, leveraging advanced technology and insights into the Amazon FBA business model [6]. - Fort Technology Inc specializes in manufacturing and selling products for the pest control and remedial repair industry [7].

Core Viewpoint - Burlington Stores, Inc. has announced the appointment of Michael Skirvin to its Board of Directors and Audit Committee, effective November 18, 2025, which is expected to enhance the company's strategic growth oversight [1][2]. Company Overview - Burlington Stores, Inc. is a nationally recognized off-price retailer, specializing in high-quality branded apparel, footwear, accessories, and home merchandise, with Fiscal 2024 net sales of $10.6 billion [4]. - The company operates 1,115 stores across 46 states, Washington D.C., and Puerto Rico, offering discounts of up to 60% off other retailers' prices [4]. Leadership Insights - John Mahoney, Chairman of the Board, emphasized that Skirvin's extensive experience will strengthen the Board's qualifications and oversight capabilities [2]. - Michael O'Sullivan, CEO, expressed excitement about Skirvin's addition, highlighting his 30 years of experience in the off-price retail sector as beneficial for the company's Burlington 2.0 strategy [2]. Michael Skirvin's Background - Michael Skirvin served as CEO of Bob's Discount Furniture from 2016 to 2020 and held various roles at The TJX Companies from 1989 to 2010, including Senior Vice President and Chief Operating Officer [3].

Core Viewpoint - Numinus Wellness Inc. reported significant growth in revenue for Q2 2025, driven by its focus on innovative mental health care and psychedelic-assisted therapies, although it also faced increased costs and operating losses [1][2]. Financial Performance - Total revenue for Q2 2025 reached CAD 1,512,435, marking an 83.8% increase from CAD 822,973 in Q2 2024 [2]. - Cost of revenue surged to CAD 1,007,691, a 175.7% increase from CAD 365,446 in the same quarter last year [2]. - Gross profit was CAD 504,744, reflecting a 10.3% increase from CAD 457,527 in Q2 2024, with a gross profit margin of 33.4%, down from 55.6% [2]. - Operating expenses rose to CAD 9,886,497, an 86.31% increase from CAD 5,306,523 in Q2 2024 [2]. - The company reported a comprehensive loss of CAD 7,705,397, compared to CAD 5,960,437 in the previous year [2]. Balance Sheet and Liquidity - Numinus ended the quarter with cash and cash equivalents amounting to CAD 705,631 [3]. Company Overview - Numinus Wellness Inc. is focused on developing and delivering innovative mental health care solutions, particularly through evidence-based psychedelic-assisted therapies, aiming to transform treatment for conditions like depression, anxiety, and substance use [4].

Financial Performance - SQM's Q2 2025 revenue reached US$1,043 million[7], gross profit was US$254 million[7], and net income totaled US$308 million[7] - Earnings per share stood at US$0.31[7] - Lithium LTM revenue reached $1,977 million[12], with a gross profit of $410 million[12] - Iodine LTM revenue reached US$985 million[23], with a gross profit of US$523 million[23] - Specialty Plant Nutrition LTM revenue reached US$946 million[33], with a gross profit of US$146 million[33] - Potassium LTM revenue reached US$217 million[40], with a gross profit of US$28 million[40] - Industrial Chemicals LTM revenue reached US$74 million[46], with a gross profit of US$28 million[46] Market Dynamics and Outlook - The global lithium market is expected to grow by approximately 17% in 2025[18] - SQM anticipates a sales volume growth of around 10% in the Lithium Chile division compared to 2024[18] - The company expects to sell approximately 20,000 tons of LCE for the International Lithium Division in 2025[18] - Global iodine demand growth is updated to less than 1% in 2025 compared to 2024[29] - SQM expects a market growth rate of around 4-5% in 2025 for Specialty Plant Nutrition[36] - Potassium sales volume for 2025 is expected to decline by 50% compared to 2024[42] Strategic Investments - Total Capex for 2025 is estimated at US$750 million, including maintenance[21] - Iodine and Nitrates total capex for 2025 is approximately US$350 million, including maintenance[31] Market Share - SQM holds approximately 17% of the global lithium chemical market[12] - SQM holds approximately 37% of the global iodine market[28] - SQM holds approximately 41% of the global KNO3 market[38] - SQM holds less than 1% of the global potash market[43] - SQM holds approximately 32% of the global industrial potassium nitrate market[49]

Financial Performance - GAAP Net Income was $102 million or $027 per share[11] - NAV-Based Total Return was 197% annualized[11] - Net Investment Income was $65 million or $017 per share[11] - Adjusted Net Investment Income was $66 million or $018 per share[11] - Net Asset Value was $2297 million or $612 per share as of June 30 2025[11] Investment Portfolio - The CLO portfolio grew by 27% to $3169 million as of June 30 2025 from $2499 million as of March 31 2025[11, 18] - CLO debt investments totaled $1489 million with 79% in the U S and 21% in Europe[11] - CLO equity investments totaled $1680 million with 92% in the U S and 8% in Europe[11] - The company purchased $906 million of CLO investments and sold $159 million[11] - The weighted average GAAP yield for the quarter based on amortized cost was 156% on the total CLO portfolio[11] Distributions - The company received $159 million in recurring cash distributions from the investment portfolio or $042 per share[11] - The distribution rate was 172% based on the August 18 2025 closing stock price of $559 and a monthly distribution of $008 per common share declared on August 7 2025[11]

FREMONT, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Interlink Electronics, Inc. (Nasdaq: LINK) (“Interlink” or the “Company”), a global leader in sensor technology and printed electronic solutions, is confirmed to present at the 2025 Gateway Conference, which is being held September 3-4, at the Four Seasons Hotel in San Francisco, CA. Interlink Chairman, President, and CEO, Steven N. Bronson, is scheduled to present on Wednesday, September 3, at 9:30 am Pacific Time (PT). The presentation will be webcast liv ...

Corporate Update - Altima Energy Inc. has provided a corporate update regarding the final acceptance from the TSXV to close its private placement for gross proceeds of $5,500,000 [2][3] - The company has issued a total of 20,000,000 Units at a price of $0.275 per Unit, each consisting of one common share and one share purchase warrant [3] Financing Details - The financing includes warrants that entitle the holder to purchase one additional common share at a price of $0.40 per share, exercisable for a period of two years [3] - A four-month hold period will be placed on all securities issued under this financing [3] - Finders' fees related to the financing have been paid in accordance with TSXV policies, and no insiders subscribed in the financing [4] Loan Settlement - A portion of the financing proceeds, amounting to $2,200,000 plus associated fees, has been allocated to settle an outstanding secured loan to an arm's length lender [5] MCTO Update - The company applied for a Management Cease Trade Order (MCTO) due to a delay in filing its audited annual financial statements for the year ended February 28, 2025 [6] - The MCTO restricts the CEO and CFO from trading in the company's securities until the required documents are filed and the MCTO is revoked [6] - The company expects to file the necessary documents by August 29, 2025, although there may be delays due to recent developments [6][7] Company Overview - Altima Energy is an oil and gas exploration and production company based in Vancouver, focusing on unlocking hydrocarbon assets across North America [9] - The company aims for efficient resource development, combining technology and industry expertise to drive operational excellence and sustainable growth [9]

Financial Highlights - Adecoagro's gross revenues for Q2 2025 were $392 million, a decrease of 1% compared to the same period last year[17] - Gross revenues for 6M25 reached $716 million, an increase of 10% compared to the same period last year[17] - Adjusted EBITDA for Q2 2025 was $55 million, a decrease of 60% compared to the same period last year[17] - Adjusted EBITDA for 6M25 was $91 million, a decrease of 60% compared to the same period last year[17] Segment Performance - Sugar, Ethanol & Energy - Sugar, Ethanol & Energy accounted for 77% of gross revenues in Q2 2025[17] - Sugar production decreased by 15% from 233,881 tons in Q2 2024 to 199,175 tons in Q2 2025[30] - Ethanol production decreased by 21% from 143,401 m3 in Q2 2024 to 98,756 m3 in Q2 2025[31] - Adjusted EBITDA for Sugar, Ethanol & Energy business decreased by 36% from $68,100 thousand in Q2 2024 to $106,886 thousand in Q2 2025[42] Farming Business - 296,057 hectares of Crops + Rice were harvested[52] - Soybean harvested area is 91,802 ha[52] - Raw milk production reached 93 million liters[52] - Farming segment experienced a significant decrease in financial performance, with profits dropping by 97% from $37,792 thousand in Q2 2024 to $1,081 thousand in Q2 2025[55] Capital Allocation - Net debt stood at $699 million[62] - 75% of debt is long term debt[63] - 70% of debt is in USD and 30% in BRL[65] - $45.2 million has been committed to shareholder distribution[71]

Fiscal Year 2025 Performance - Consolidated net revenue for Q4 FY25 was $262.9 million[13] - Supply Chain Services net revenue for Q4 FY25 reached $170 million, exceeding expectations[13] - Performance Services net revenue excluding Contigo Health for Q4 FY25 was $88 million, below the implied guidance[13] - Adjusted EBITDA excluding Contigo Health for Q4 FY25 was $71.1 million, surpassing expectations[13] - The company had cash flow from operations of $417.8 million for the fiscal year ended June 30, 2025[16] - Free cash flow was $180.5 million for the fiscal year ended June 30, 2025[17] Capital Allocation - The company repurchased $800 million of Class A common stock under the $1 billion share repurchase authorization[18] - Dividends of $77.4 million were paid to stockholders in fiscal year 2025[18] Fiscal Year 2026 Guidance - Total net revenue excluding Contigo Health is projected to be between $940 million and $1 billion[21] - Supply Chain Services revenue is expected to be between $590 million and $620 million[21] - Performance Services revenue excluding Contigo Health is guided to be between $350 million and $380 million[21]